SLC6A4 and major depressive disorder: This is best illustrated by the SLC6A4 rs25331 variant, as medication recommendation concordance between different DSTs for patients with MDD was found to be partly dependent on whether a PGx test included this variant.5 Modeling combinatorial effects across multiple genes is also challenged by differences in ethnicity and clinical characteristics of the patient cohorts used to validate PGx tests.